GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vidac Pharma Holding PLC (STU:T9G) » Definitions » Net Margin %

Vidac Pharma Holding (STU:T9G) Net Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Vidac Pharma Holding Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Vidac Pharma Holding's Net Income for the six months ended in Jun. 2024 was €-0.51 Mil. Vidac Pharma Holding's Revenue for the six months ended in Jun. 2024 was €0.00 Mil. Therefore, Vidac Pharma Holding's net margin for the quarter that ended in Jun. 2024 was 0.00%.

The historical rank and industry rank for Vidac Pharma Holding's Net Margin % or its related term are showing as below:


STU:T9G's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -119.77
* Ranked among companies with meaningful Net Margin % only.

Vidac Pharma Holding Net Margin % Historical Data

The historical data trend for Vidac Pharma Holding's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vidac Pharma Holding Net Margin % Chart

Vidac Pharma Holding Annual Data
Trend Dec21 Dec22 Dec23
Net Margin %
- - -

Vidac Pharma Holding Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Vidac Pharma Holding's Net Margin %

For the Biotechnology subindustry, Vidac Pharma Holding's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vidac Pharma Holding's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vidac Pharma Holding's Net Margin % distribution charts can be found below:

* The bar in red indicates where Vidac Pharma Holding's Net Margin % falls into.


;
;

Vidac Pharma Holding Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Vidac Pharma Holding's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-1.48/0
= %

Vidac Pharma Holding's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-0.508/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vidac Pharma Holding  (STU:T9G) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Vidac Pharma Holding Net Margin % Related Terms

Thank you for viewing the detailed overview of Vidac Pharma Holding's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vidac Pharma Holding Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vidac Pharma Holding PLC (STU:T9G) » Definitions » Net Margin %
Comparable Companies
XTER:MDG1 XTER:HPHA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM HKSE:02269 BMRN RPRX XKRX:196170 OCSE:GMAB MRNA
Traded in Other Exchanges
N/A
Address
Wenlock Road, 20-22, London, GBR, N1 7GU
Website
https://www.vidacpharma.com
Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company developing first-in-class oncologic and onco-dermatologic therapies. Its drug, VDA-1102, is at the clinical development stage as an ointment for patients with actinic keratosis, an early form of skin cancer, and in a separate trial for an indication of cutaneous T-cell lymphoma (CTCL). A second molecule, VDA-1275, with possible application for a wide range of solid tumors.

Vidac Pharma Holding Headlines

No Headlines